Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.pbb.2024.173758 | DOI Listing |
Publication Analysis
Top Keywords
corrigendum "dl0410
4
"dl0410 reverse
4
reverse cognitive
4
cognitive impairment
4
impairment synaptic
4
synaptic loss
4
loss reduce
4
reduce plaque
4
plaque load
4
load app/ps1
4
Similar Publications
Corrigendum: Multi-protection of DL0410 in ameliorating cognitive defects in D-galactose induced aging mice.
Front Aging Neurosci
June 2024
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
[This corrects the article DOI: 10.3389/fnagi.2017.
View Article and Find Full Text PDFCorrigendum to "DL0410 can reverse cognitive impairment, synaptic loss and reduce plaque load in APP/PS1 transgenic mice" [Pharmacol. Biochem. Beha. Volume 139, Part A, December 2015, Pages 15-26].
Pharmacol Biochem Behav
June 2024
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China; Beijing Key Laboratory of Drug Target and Screening Research, Beijing 100050, China. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!